Compass Therapeutics, Inc. financial data

Symbol
CMPX on Nasdaq
Location
80 Guest Street, Boston, MA
State of incorporation
Delaware
Fiscal year end
December 31
Former names
Olivia Ventures, Inc. (to 6/8/2020)
Latest financial report
10-Q - Q2 2024 - Aug 12, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 2.09K % +43.9%
Debt-to-equity 5.22 % -37.3%
Return On Equity -30.9 % -16%
Return On Assets -29.4 % -19.4%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 138M shares +7.95%
Common Stock, Shares, Outstanding 138M shares +8.01%
Entity Public Float 283M USD +53.8%
Common Stock, Value, Issued 14K USD +7.69%
Weighted Average Number of Shares Outstanding, Basic 138M shares +8.57%

Income Statement

Label TTM Value / Value Unit Change %
General and Administrative Expense 14M USD +17.3%
Operating Income (Loss) -55.1M USD -13.6%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -47.2M USD -10.7%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -47.2M USD -10.7%
Earnings Per Share, Basic -0.36 USD/shares +2.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 19.4M USD +0.65%
Marketable Securities, Current 127M USD -15.2%
Cash, Cash Equivalents, and Short-term Investments 175M USD
Assets, Current 154M USD -12.4%
Property, Plant and Equipment, Net 592K USD -50.8%
Operating Lease, Right-of-Use Asset 1.15M USD -51.7%
Other Assets, Noncurrent 320K USD 0%
Assets 156M USD -13.2%
Accounts Payable, Current 1.19M USD +64.6%
Accrued Liabilities, Current 7.23M USD -7.67%
Liabilities, Current 9.51M USD -1.97%
Operating Lease, Liability, Noncurrent 0 USD -100%
Liabilities 9.51M USD -12.7%
Accumulated Other Comprehensive Income (Loss), Net of Tax -91K USD +82.1%
Retained Earnings (Accumulated Deficit) -339M USD -16.2%
Stockholders' Equity Attributable to Parent 146M USD -13.2%
Liabilities and Equity 156M USD -13.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -13.9M USD -13.6%
Net Cash Provided by (Used in) Financing Activities 17.4M USD +42420%
Net Cash Provided by (Used in) Investing Activities -4.1M USD -196%
Common Stock, Shares Authorized 300M shares 0%
Common Stock, Shares, Issued 138M shares +7.95%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -554K USD +93%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD -100%
Deferred Tax Assets, Gross 44.3M USD +53.6%
Operating Lease, Liability 1.09M USD -53.6%
Depreciation 200K USD 0%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -46.8M USD -9.72%
Lessee, Operating Lease, Liability, to be Paid 1.12M USD -55%
Property, Plant and Equipment, Gross 7.17M USD +0.27%
Operating Lease, Liability, Current 1.09M USD -5.14%
Lessee, Operating Lease, Liability, to be Paid, Year Two 543K USD -60.6%
Lessee, Operating Lease, Liability, to be Paid, Year One 543K USD -60.6%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 30K USD -78.4%
Lessee, Operating Lease, Liability, to be Paid, Year Three 543K USD -60.7%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 0 USD
Operating Lease, Payments 1.3M USD 0%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 485K USD -40%
Share-based Payment Arrangement, Expense 7.35M USD +41.1%
Interest Expense 0 USD -100%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%